Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells

For many tumor types chemotherapy still represents the therapy of choice and many standard treatments are based on the use of platinum (PT) drugs. However, de novo or acquired resistance to platinum is frequent and leads to disease progression. In Epithelial Ovarian Cancer (EOC) patients, PT-resista...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncogene
Päätekijät: Ranzuglia, Valentina, Lorenzon, Ilaria, Pellarin, Ilenia, Sonego, Maura, Dall’Acqua, Alessandra, D’Andrea, Sara, Lovisa, Sara, Segatto, Ilenia, Coan, Michela, Polesel, Jerry, Serraino, Diego, Sabatelli, Patrizia, Spessotto, Paola, Belletti, Barbara, Baldassarre, Gustavo, Schiappacassi, Monica
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529585/
https://ncbi.nlm.nih.gov/pubmed/32848212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01433-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia